The FDA announced on Sept. 5, 2025, that Microvention Inc. is recalling Flow Re-Direction Endoluminal Devices due to potential manufacturing issues with tantalum length and attachment patterns. The agency issued recall number Z-0108-2026 for the voluntary Class II recall affecting 467 units distributed worldwide.
How to tell if you have it
- Brand: Microvention
- Product: Flow Re-Direction Endoluminal Devices: FRED 27, REF: FRED5019, FRED5029, FRED4528, FRED4026, FRED5526, FRED4508
- Product: FRED X 27, REF: XFRED4017-MVE, XFRED4528-MVE, MV-F501427X, XFRED4518-MVE, XFRED5526-MVE, XFRED4539-MVE
- Product: FREDX5522-PMA, FREDX3522-PMA, FREDX4525-PMA, FREDX5015-PMA, FREDX5532-PMA, FREDX4013-PMA, FREDX3513-PMA, FREDX4515-PMA, FREDX3517-PMA
- Product: MV-F352427X
- Lot codes include REF/UDI-DI(Lot) codes such as FRED5019/00811425020388(0000235839), 00842429117163(0000544498) and others listed in the record
- Quantity: 467 units
The hazard
According to the FDA, the flow diverter may have a manufacturing issue related to the tantalum length and/or tantalum attachment pattern. This defect may lead the device to be incompletely open or not properly apposed to the vessel wall, necessitating device recapture and withdrawal of the delivery system and microcatheter together. Insufficient apposition could lead to long-term health consequences.
Context
GovInfoNow's records show Microvention Inc. has 15 other recalls on record since Aug. 7, 2017. Recent Microvention recalls include the Bobby Balloon Guide Catheter Recall on April 30, 2026, due to balloon pinhole defects, and the LVIS Stent Device Recall on April 6, 2026, for risk of vessel injury from manufacturing errors. Other recent recalls of similar products include the Micro Therapeutics Pipeline Flex Embolization Device recall (June 8, 2026) and the CleverCut Single Use Sphincterotome V Recall (Jan. 7, 2026).